预测阿尔茨海默病的个性化进展使用结构性MRI和人口空间时间先验
Yan Zhao1, Tongtong Che2, Xiuying Wang3
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Frontiers in aging neuroscience
|February 20, 2026
概括
这项研究引入了一种新型的进度地图引导生成对抗网络 (pg-GAN),使用MRI扫描准确预测阿尔茨海默病的进展. 该模型通过结合人口级数据来增强个人预测,提高诊断准确性.
科学领域:
- 神经成像是一种神经成像.
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 阿尔茨海默病 (AD) 导致渐进的神经退行,需要通过结构磁共振成像 (sMRI) 进行准确的跟踪.
- 生成模型可以预测未来的MRI扫描以模拟疾病进展,但生成精确解剖的高保真图像仍然是一个挑战.
研究的目的:
- 利用纵向MRI数据开发一个生成模型,准确地预测阿尔茨海默病中未来的大脑变化.
- 为了提高产生MRI扫描的解剖学准确性和准确性,用于个别患者的预测.
主要方法:
- 提出了一个以进度图为指导的生成对抗网络 (pg-GAN),利用人口层面的纵向数据.
- 从扫描中的强度残留物创建了进度图,以捕捉体积大脑进化.
- 这些地图被集成到一个生成对抗网络 (GAN) 中,使用特征智能融合模块 (FFM) 进行个人MRI预测.
主要成果:
- 在阿尔茨海默病神经成像倡议 (ADNI) 数据集的实验中,有210名参与者证明了pg-GAN对其他模型的优越性.
- 定量分析显示,正常化根平均平方误差 (NRMSE) 从0.1623降至0.1549.
- 峰值信号噪声比 (PSNR) 从25.9353dB提高到26.3157dB,表明图像质量得到了提高.
结论:
- 将组级进展先验集成到生成模型中,可以显著提高预测MRI的准确性和解剖学准确性.
- 这种方法改善了疾病进展的voxel级可视化.
- 这有助于开发精确治疗阿尔茨海默病的方法.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...